
Sign up to save your podcasts
Or


Eli Lilly Purchases Ventyx Biosciences for $1.2 billion. Ventyx Biosciences is advancing a gallimaufry of treatments. Including but not limited to, oral therapies for inflammatory bowel diseases. Thank you for listening. Visit myoddman.com and subscribe for more! Super News #122.
By Preston Olson5
22 ratings
Eli Lilly Purchases Ventyx Biosciences for $1.2 billion. Ventyx Biosciences is advancing a gallimaufry of treatments. Including but not limited to, oral therapies for inflammatory bowel diseases. Thank you for listening. Visit myoddman.com and subscribe for more! Super News #122.